Heraeus Medical, Inc., a prominent player in the medical technology industry, is headquartered in the United States and operates extensively across North America and Europe. Founded in 1851, the company has established itself as a leader in the development of innovative biomaterials and medical devices, particularly in orthopaedics and trauma care. Heraeus Medical is renowned for its core products, including bone cements and surgical solutions, which are distinguished by their superior quality and performance. The company’s commitment to research and development has led to significant advancements in patient care, solidifying its market position as a trusted provider in the healthcare sector. With a rich history and a focus on enhancing surgical outcomes, Heraeus Medical continues to set benchmarks in the medical field.
How does Heraeus Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Electrical Machinery Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Heraeus Medical, Inc.'s score of 23 is lower than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Heraeus Medical, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established any documented reduction targets or climate pledges. In the absence of specific emissions data or commitments, it is important to note that many organisations in the medical sector are increasingly focusing on sustainability and climate action. This includes setting science-based targets and engaging in initiatives aimed at reducing their carbon footprint. However, without specific information from Heraeus Medical, Inc., it is unclear what their current strategies or commitments may be in relation to climate change and carbon emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Heraeus Medical, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.